AKT2 expression
|
HER2 Positive Breast Cancer
|
AKT2 expression
|
HER2 Positive Breast Cancer
|
trastuzumab Sensitive: C3 – Early Trials
|
trastuzumab Sensitive: C3 – Early Trials
|
AKT2 expression
|
B Acute Lymphoblastic Leukemia
|
AKT2 expression
|
B Acute Lymphoblastic Leukemia
|
CCT128930 Sensitive: D – Preclinical
|
CCT128930 Sensitive: D – Preclinical
|